Fuso Pharmaceutical Industries (TSE:4538) LT-Debt-to-Total-Asset: 0.02 (As of Mar. 2026)

What is Fuso Pharmaceutical Industries LT-Debt-to-Total-Asset?

Fuso Pharmaceutical Industries TSE:4538 +0.28% 51 LT-Debt-to-Total-Asset is 0.02 as of Mar. 2026. GuruFocus rates TSE:4538 with a GF Score™ of 51/100 and a GF Value™ of 円2,553.36 (Modestly Undervalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Fuso Pharmaceutical Industries's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.02.

Fuso Pharmaceutical Industries's long-term debt to total assets ratio declined from Mar. 2025 (0.03) to Mar. 2026 (0.02). It may suggest that Fuso Pharmaceutical Industries is progressively becoming less dependent on debt to grow their business.

Fuso Pharmaceutical Industries (TSE:4538) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Fuso Pharmaceutical Industries LT-Debt-to-Total-Asset Related Terms

Fuso Pharmaceutical Industries LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries LT-Debt-to-Total-Asset Chart

Fuso Pharmaceutical Industries Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.09

0.03

0.02

Fuso Pharmaceutical Industries Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.09	0.04	0.03	0.03	0.02

51GF Score

Fuso Pharmaceutical Industries Ltd TSE:4538

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fuso Pharmaceutical Industries LT-Debt-to-Total-Asset Calculation

Fuso Pharmaceutical Industries's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )	/	Total Assets (A: Mar. 2026 )
	=	1858	/	90323
	=	0.02

Fuso Pharmaceutical Industries's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	1858	/	90323
	=	0.02

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.02 mean?

Fuso Pharmaceutical Industries (TSE:4538) has a LT-Debt-to-Total-Asset of 0.02 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Fuso Pharmaceutical Industries and its competitors.

Is Fuso Pharmaceutical Industries' LT-Debt-to-Total-Asset too high?

Fuso Pharmaceutical Industries' current LT-Debt-to-Total-Asset is 0.02. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Fuso Pharmaceutical Industries' LT-Debt-to-Total-Asset compare to ZTS and UTHR?

Fuso Pharmaceutical Industries' LT-Debt-to-Total-Asset of 0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Fuso Pharmaceutical Industries and its competitors. Fuso Pharmaceutical Industries's current LT-Debt-to-Total-Asset is 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fuso Pharmaceutical Industries stock overvalued right now?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,553.36, compared to a current price of 円2,156.00 — trading 15.6% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.02. Fuso Pharmaceutical Industries' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current LT-Debt-to-Total-Asset is 0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,156.00 is trading 15.6% below its estimated GF Value™ of 円2,553.36. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

LT-Debt-to-Total-Asset: 0.02
GF Value™: 円2,553.36 vs. price of 円2,156.00 (15.6% below fair value)
GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuso Pharmaceutical Industries Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSE:2929 TSE:4574 TSE:4512 TSE:4524 TSE:4597 TSE:4539 TSE:4892 TSE:4582 TSE:9273 TSE:311A XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045

Website https://www.fuso-pharm.co.jp

Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.

51GF Score

Get the complete analysis for TSE:4538

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,156.00

Price

円2,553.36

GF Value

View TSE:4538 Analysis

See LT-Debt-to-Total-Asset data for all stocks →